Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral™ (2013-2014 Season) in Adults Aged 18 Years and Older

NCT01878825 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Fluviral™

Sponsor

GlaxoSmithKline